Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Liberty Latin America Class C
LILAK
$1.68B
| $683K | ﹤0.01% |
90,992
+38,679
| +74% | +$308K |
|
|
IMA
2952
ImageneBio Inc
IMA
$64.7M
| $683K | ﹤0.01% |
16,503
-114
| -0.7% | -$5.24K |
|
2953
Hawaiian Electric Industries
HE
$2.17B
| $683K | ﹤0.01% |
17,778
+2,399
| +16% | +$97.2K |
|
2954
Helix Energy Solutions
HLX
$1.39B
| $682K | ﹤0.01% |
88,157
+2,186
| +3% | +$17.1K |
|
2955
Vanda Pharmaceuticals
VNDA
$318M
| $681K | ﹤0.01% |
100,294
+3,550
| +4% | +$25K |
|
2956
Palomar
PLMR
$3.58B
| $680K | ﹤0.01% |
12,325
+377
| +3% | +$20.2K |
|
2957
Bank of N.T. Butterfield & Son
NTB
$2.44B
| $680K | ﹤0.01% |
25,194
+11,843
| +89% | +$378K |
|
2958
News Corp Class B
NWS
$17.3B
| $679K | ﹤0.01% |
38,978
-45,212
| -54% | -$835K |
|
|
SJR
2959
DELISTED
Shaw Communications Inc.
SJR
| $679K | ﹤0.01% |
22,713
-669,910
| -97% | -$19.4M |
|
2960
Calumet Specialty Products
CLMT
$3.66B
| $678K | ﹤0.01% |
39,030
+34,399
| +743% | +$611K |
|
2961
NextNav
NN
$1.85B
| $678K | ﹤0.01% |
333,774
+115,792
| +53% | +$310K |
|
2962
CorMedix
CRMD
$599M
| $677K | ﹤0.01% |
163,523
+20,391
| +14% | +$83.4K |
|
2963
Ingles Markets
IMKTA
$1.74B
| $676K | ﹤0.01% |
7,621
-8,497
| -53% | -$788K |
|
|
SMC
2964
Summit Midstream
SMC
$428M
| $675K | ﹤0.01% |
43,973
+35,147
| +398% | +$595K |
|
|
GRP.U
2965
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $675K | ﹤0.01% |
10,890
-15,519
| -59% | -$924K |
|
2966
Ooma
OOMA
$606M
| $673K | ﹤0.01% |
53,759
+5,697
| +12% | +$76.3K |
|
2967
Harrow
HROW
$1.47B
| $672K | ﹤0.01% |
31,774
+15,201
| +92% | +$259K |
|
2968
Rocket Companies
RKT
$40.3B
| $672K | ﹤0.01% |
74,119
-312,236
| -81% | -$2.69M |
|
|
AMWD
2969
DELISTED
American Woodmark
AMWD
| $671K | ﹤0.01% |
12,881
+882
| +7% | +$47.7K |
|
2970
Titan International
TWI
$470M
| $670K | ﹤0.01% |
63,948
+3,877
| +6% | +$54.9K |
|
|
SGMO
2971
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $667K | ﹤0.01% |
379,016
-119,448
| -24% | -$341K |
|
2972
PUT
HDFC Bank
HDB
$122B
| $667K | ﹤0.01% |
+20,000
| New | +$669K |
|
|
SCPH
2973
DELISTED
scPharmaceuticals
SCPH
| $666K | ﹤0.01% |
+73,448
| New | +$538K |
|
|
CIM
2974
Chimera Investment
CIM
$1.05B
| $666K | ﹤0.01% |
39,347
-393,083
| -91% | -$7.52M |
|
2975
Ezcorp Inc
EZPW
$1.88B
| $665K | ﹤0.01% |
77,339
-19,858
| -20% | -$175K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.